Clinical Roundup NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis April 07, 2023Vol.49 No.14
Clinical Roundup Metastasis-directed radiation therapy + hormone therapy improves PFS for advanced prostate cancer April 07, 2023Vol.49 No.14
Clinical Roundup ChristianaCare researchers show cancer stem cell populations in CRC are diverse, not uniform April 07, 2023Vol.49 No.14
Drugs & Targets FDA approves Keytruda + Padcev for first-line treatment of certain patients with locally advanced or metastatic urothelial cancer April 07, 2023Vol.49 No.14
Clinical Roundup Keytruda + chemo improved PFS as first-line therapy for advanced or recurrent endometrial carcinoma, regardless of MMR status March 31, 2023Vol.49 No.13
Clinical Roundup Phase III RUBY trial demonstrates potential of Jemperli + chemo to redefine treatment of advanced or recurrent endometrial cancer March 31, 2023Vol.49 No.13
Clinical Roundup Sylvester investigators identify potential targets to overcome treatment resistance in TNBC March 31, 2023Vol.49 No.13
Clinical Roundup Kisqali phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in early breast cancer March 31, 2023Vol.49 No.13
Clinical Roundup Phase II study shows surgery is an effective alternative to chemo and radiation for early metastatic testicular cancer March 31, 2023Vol.49 No.13
